Log in to save to my catalogue

Evolution of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence among employee...

Evolution of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence among employee...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8668398

Evolution of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence among employees of a US academic children’s hospital during coronavirus disease 2019 (COVID-19) pandemic

About this item

Full title

Evolution of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence among employees of a US academic children’s hospital during coronavirus disease 2019 (COVID-19) pandemic

Publisher

New York, USA: Cambridge University Press

Journal title

Infection control and hospital epidemiology, 2022-11, Vol.43 (11), p.1647-1655

Language

English

Formats

Publication information

Publisher

New York, USA: Cambridge University Press

More information

Scope and Contents

Contents

To describe the cumulative seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies during the coronavirus disease 2019 (COVID-19) pandemic among employees of a large pediatric healthcare system.
Prospective observational cohort study open to adult employees at the Children's Hospital of Philadelphia, conducted Apri...

Alternative Titles

Full title

Evolution of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence among employees of a US academic children’s hospital during coronavirus disease 2019 (COVID-19) pandemic

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8668398

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8668398

Other Identifiers

ISSN

0899-823X,1559-6834

E-ISSN

1559-6834

DOI

10.1017/ice.2021.487

How to access this item